Published in Clin Infect Dis on September 12, 2012
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection. Clin Infect Dis (2013) 3.15
Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis (2015) 2.39
Dentists, antibiotics and Clostridium difficile-associated disease. Br Dent J (2015) 2.10
Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis (2013) 1.95
Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev (2013) 1.85
Role of the intestinal microbiota in resistance to colonization by Clostridium difficile. Gastroenterology (2014) 1.77
Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance. Gut Microbes (2013) 1.41
Editorial commentary: 027, 078, and others: going beyond the numbers (and away from the hypervirulence). Clin Infect Dis (2012) 1.41
Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls. MBio (2014) 1.40
NAP1 strain type predicts outcomes from Clostridium difficile infection. Clin Infect Dis (2014) 1.31
Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review. PLoS One (2014) 1.23
Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS One (2013) 1.22
The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Anaerobe (2013) 1.14
Epidemiology of Clostridium difficile infection. J Pharm Pract (2013) 1.10
International Clostridium difficile animal strain collection and large diversity of animal associated strains. BMC Microbiol (2014) 1.09
Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB. PLoS Pathog (2013) 1.08
Poor functional status as a risk factor for severe Clostridium difficile infection in hospitalized older adults. J Am Geriatr Soc (2013) 1.05
Clostridium difficile ribotype diversity at six health care institutions in the United States. J Clin Microbiol (2013) 1.04
Laboratory diagnosis of bacterial gastroenteritis. Clin Microbiol Rev (2015) 1.03
Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99
Whole genome sequencing reveals potential spread of Clostridium difficile between humans and farm animals in the Netherlands, 2002 to 2011. Euro Surveill (2014) 0.99
Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J Pediatr (2013) 0.98
Evaluation of portability and cost of a fluorescent PCR ribotyping protocol for Clostridium difficile epidemiology. J Clin Microbiol (2015) 0.94
Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping. Infect Control Hosp Epidemiol (2013) 0.94
Regarding "Clostridium difficile ribotype does not predict severe infection". Clin Infect Dis (2013) 0.93
Virulence and clinical outcomes in Clostridium difficile infection: a complex business. Clin Infect Dis (2012) 0.93
Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality. Eur J Clin Microbiol Infect Dis (2014) 0.92
A clinical and epidemiological review of non-toxigenic Clostridium difficile. Anaerobe (2013) 0.91
Clostridium difficile PCR Ribotype 018, a Successful Epidemic Genotype. J Clin Microbiol (2015) 0.91
Characterization of temperate phages infecting Clostridium difficile isolates of human and animal origins. Appl Environ Microbiol (2014) 0.89
Variation in germination of Clostridium difficile clinical isolates correlates to disease severity. Anaerobe (2015) 0.88
Challenges for standardization of Clostridium difficile typing methods. J Clin Microbiol (2013) 0.88
Elevated lactoferrin is associated with moderate to severe Clostridium difficile disease, stool toxin, and 027 infection. Eur J Clin Microbiol Infect Dis (2013) 0.87
In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent. Infect Control Hosp Epidemiol (2015) 0.87
The systemic inflammatory response to Clostridium difficile infection. PLoS One (2014) 0.85
Development and validation of an internationally-standardized, high-resolution capillary gel-based electrophoresis PCR-ribotyping protocol for Clostridium difficile. PLoS One (2015) 0.85
Elevated fecal calprotectin associates with adverse outcomes from Clostridium difficile infection in older adults. Infect Dis (Lond) (2016) 0.84
Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolates. Infect Immun (2014) 0.83
Clostridium difficile infection caused by binary toxin-positive strains. Emerg Infect Dis (2013) 0.83
Multicenter evaluation of the Verigene Clostridium difficile nucleic acid assay. J Clin Microbiol (2013) 0.83
Development and optimization of a high-throughput assay to measure neutralizing antibodies against Clostridium difficile binary toxin. Clin Vaccine Immunol (2014) 0.82
Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria. Wien Klin Wochenschr (2014) 0.81
Measuring the impact of Clostridium difficile Infection with the NAP1 strain on severity and mortality. Clin Infect Dis (2014) 0.81
Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort. Clin Infect Dis (2015) 0.81
The role of the humoral immune response to Clostridium difficile toxins A and B in susceptibility to C. difficile infection: a case-control study. Anaerobe (2014) 0.79
Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review. Curr Top Med Chem (2014) 0.79
Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities. J Hosp Infect (2014) 0.78
Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea. Infect Chemother (2013) 0.78
A comparison of Clostridium difficile ribotypes circulating in Australian hospitals and communities. J Clin Microbiol (2016) 0.77
Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey. Wien Klin Wochenschr (2015) 0.76
Serum 25-Hydroxyvitamin D Levels are not Associated with Adverse Outcomes in Clostridium Difficile Infection. Infect Dis Rep (2015) 0.76
Reply to Walker et al. Clin Infect Dis (2013) 0.75
Reply to McDonald. Clin Infect Dis (2012) 0.75
Prevalence of human norovirus and Clostridium difficile coinfections in adult hospitalized patients. Clin Epidemiol (2016) 0.75
Surface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune response. BMC Evol Biol (2017) 0.75
Development of a Novel Vaccine Containing Binary Toxin for the Prevention of Clostridium difficile Disease with Enhanced Efficacy against NAP1 Strains. PLoS One (2017) 0.75
Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal disease. BMC Microbiol (2016) 0.75
Growth Patterns of Clostridium difficile - Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study. PLoS One (2016) 0.75
Fulminant Pseudomembranous Colitis Presenting as Sigmoid Stricture and Severe Polyposis with Clinical Response to Intracolonic Vancomycin. Case Rep Med (2016) 0.75
An exploratory study to evaluate Clostridium difficile polymerase chain reaction ribotypes and infection outcomes. Infect Drug Resist (2016) 0.75
Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains. PLoS One (2016) 0.75
Binary toxin and its clinical importance in Clostridium difficile infection, Belgium. Eur J Clin Microbiol Infect Dis (2016) 0.75
Does Adjunctive Tigecycline Improve Outcomes in Severe-Complicated, Nonoperative Clostridium difficile Infection? Open Forum Infect Dis (2017) 0.75
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol (2011) 220.97
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med (2005) 18.10
Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet (2005) 12.54
Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis (2006) 7.64
Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol (2007) 5.37
Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol (2004) 4.53
Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol Lett (1999) 4.27
The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol (2011) 3.92
Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis (2008) 3.49
Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis (2004) 3.42
Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J Clin Microbiol (2002) 3.30
Clostridium difficile infection caused by the epidemic BI/NAP1/027 strain. Gastroenterology (2009) 3.29
tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J Clin Microbiol (2006) 2.49
Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J Bacteriol (2010) 2.29
Characterization of Clostridium difficile isolates using capillary gel electrophoresis-based PCR ribotyping. J Med Microbiol (2008) 2.17
New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection. Clin Microbiol Infect (2008) 2.15
Mortality of patients with antibiotic-associated diarrhoea: the impact of Clostridium difficile. J Hosp Infect (2008) 1.91
Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS One (2008) 1.88
Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis (2011) 1.79
Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect Control Hosp Epidemiol (2010) 1.73
Correlation of disease severity with fecal toxin levels in patients with Clostridium difficile-associated diarrhea and distribution of PCR ribotypes and toxin yields in vitro of corresponding isolates. J Clin Microbiol (2006) 1.71
The challenges posed by reemerging Clostridium difficile infection. Clin Infect Dis (2007) 1.66
Clostridium difficile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin Gastroenterol Hepatol (2009) 1.66
Laboratory maintenance of Clostridium difficile. Curr Protoc Microbiol (2009) 1.59
Comparative analysis of BI/NAP1/027 hypervirulent strains reveals novel toxin B-encoding gene (tcdB) sequences. J Med Microbiol (2008) 1.54
Rapid molecular characterization of Clostridium difficile and assessment of populations of C. difficile in stool specimens. J Clin Microbiol (2009) 1.48
Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007. Anaerobe (2009) 1.47
Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile. J Infect (2011) 1.45
Frequency of binary toxin genes among Clostridium difficile strains that do not produce large clostridial toxins. J Clin Microbiol (2003) 1.43
Predictors of death after Clostridium difficile infection: a report on 128 strain-typed cases from a teaching hospital in the United Kingdom. Clin Infect Dis (2010) 1.41
Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes. J Clin Microbiol (2011) 1.37
High prevalence of tcdC deletion-carrying Clostridium difficile and lack of association with disease severity. Diagn Microbiol Infect Dis (2009) 1.15
Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score. J Hosp Infect (2011) 1.11
Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting. Scand J Infect Dis (2011) 1.02
Clinical predictors and risk factors for relapsing Clostridium difficile infection. Am J Med Sci (2010) 1.02
Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia. Anaerobe (2011) 0.93
Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J Gastroenterol (2008) 0.90
Reproducible community dynamics of the gastrointestinal microbiota following antibiotic perturbation. Infect Immun (2009) 7.48
Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis (2008) 6.21
Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet (2006) 5.65
Predictors of survival from out-of-hospital cardiac arrest: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes (2009) 5.65
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med (2006) 4.50
Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med (2013) 3.65
Decade-long bacterial community dynamics in cystic fibrosis airways. Proc Natl Acad Sci U S A (2012) 3.43
Opening of specialty cardiac hospitals and use of coronary revascularization in medicare beneficiaries. JAMA (2007) 2.81
Acute infection contributes to racial disparities in stroke mortality. Neurology (2014) 2.70
Liability claims and costs before and after implementation of a medical error disclosure program. Ann Intern Med (2010) 2.59
Effect of nonpayment for hospital-acquired, catheter-associated urinary tract infection: a statewide analysis. Ann Intern Med (2012) 2.44
From structure to function: the ecology of host-associated microbial communities. Microbiol Mol Biol Rev (2010) 2.42
The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol (2013) 2.40
The interplay between microbiome dynamics and pathogen dynamics in a murine model of Clostridium difficile Infection. Gut Microbes (2011) 2.37
Home intravenous antimicrobial infusion therapy: a viable option in older adults. J Am Geriatr Soc (2007) 2.16
Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteria. Infect Control Hosp Epidemiol (2012) 2.15
Detection of the Klebsiella pneumoniae carbapenemase type 2 Carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol (2008) 2.13
High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care (2010) 2.12
Operator experience and carotid stenting outcomes in Medicare beneficiaries. JAMA (2011) 2.12
Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis (2010) 2.09
Is statin use associated with reduced mortality after pneumonia? A systematic review and meta-analysis. Am J Med (2012) 2.09
Decision aids and breast cancer: do they influence choice for surgery and knowledge of treatment options? J Clin Oncol (2007) 2.09
Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc (2013) 2.05
Evolutionary genetics of a new pathogenic Escherichia species: Escherichia albertii and related Shigella boydii strains. J Bacteriol (2005) 2.01
Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol (2008) 2.00
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis (2005) 1.93
Skin-derived fibroblasts from long-lived species are resistant to some, but not all, lethal stresses and to the mitochondrial inhibitor rotenone. Aging Cell (2006) 1.89
Association between sarcopenia and the risk of serious infection among adults undergoing liver transplantation. Liver Transpl (2013) 1.88
Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis (2010) 1.85
Suppression of Clostridium difficile in the gastrointestinal tracts of germfree mice inoculated with a murine isolate from the family Lachnospiraceae. Infect Immun (2012) 1.79
Fever and hypothermia in systemic inflammation: recent discoveries and revisions. Front Biosci (2005) 1.75
Interaction between the intestinal microbiota and host in Clostridium difficile colonization resistance. Trends Microbiol (2012) 1.70
Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2003) 1.69
Association between nonverbal communication during clinical interactions and outcomes: a systematic review and meta-analysis. Patient Educ Couns (2011) 1.69
Specialty care and the patient-centered medical home. Med Care (2011) 1.68
Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun (2005) 1.67
Prostaglandin E(2) inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling. Am J Physiol Lung Cell Mol Physiol (2006) 1.66
Widespread colonization of the lung by Tropheryma whipplei in HIV infection. Am J Respir Crit Care Med (2013) 1.66
Efficacy of peer support interventions for depression: a meta-analysis. Gen Hosp Psychiatry (2010) 1.63
Clostridium difficile infection in the "oldest" old: clinical outcomes in patients aged 80 and older. J Am Geriatr Soc (2009) 1.62
Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood (2005) 1.62
Gene expression patterns in calorically restricted mice: partial overlap with long-lived mutant mice. Mol Endocrinol (2002) 1.61
Blood culture contamination: a randomized trial evaluating the comparative effectiveness of 3 skin antiseptic interventions. Infect Control Hosp Epidemiol (2012) 1.61
Relationship between COMLEX and USMLE scores among osteopathic medical students who take both examinations. Teach Learn Med (2010) 1.60
The microbiome of the lung. Transl Res (2012) 1.59
Perturbation of the small intestine microbial ecology by streptomycin alters pathology in a Salmonella enterica serovar typhimurium murine model of infection. Infect Immun (2009) 1.59
Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis (2008) 1.58
Area socioeconomic status and mortality after coronary artery bypass graft surgery: the role of hospital volume. Am Heart J (2007) 1.57
Antibiotic administration alters the community structure of the gastrointestinal micobiota. Gut Microbes (2010) 1.57
Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals. MBio (2015) 1.56
Critical role of prostaglandin E2 overproduction in impaired pulmonary host response following bone marrow transplantation. J Immunol (2006) 1.56
Depression, antidepressant medications, and risk of Clostridium difficile infection. BMC Med (2013) 1.54
Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases. Proc Natl Acad Sci U S A (2002) 1.54
Prostaglandin E2 suppresses bacterial killing in alveolar macrophages by inhibiting NADPH oxidase. Am J Respir Cell Mol Biol (2007) 1.52
Impact of an antimicrobial stewardship program comprehensive care bundle on management of candidemia. Pharmacotherapy (2013) 1.51
Prevention, diagnosis, and management of postoperative delirium in older adults. J Am Coll Surg (2009) 1.51
Stabilization of the murine gut microbiome following weaning. Gut Microbes (2012) 1.49
Physician specialty and carotid stenting among elderly medicare beneficiaries in the United States. Arch Intern Med (2011) 1.49
Antimicrobial use among patients receiving palliative care consultation. Am J Hosp Palliat Care (2009) 1.49
Prostaglandin E(2) inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. Am J Respir Cell Mol Biol (2004) 1.47
Recent trends in cost-related medication nonadherence among stroke survivors in the United States. Ann Neurol (2013) 1.46
Microbial ecology of the murine gut associated with the development of dextran sodium sulfate-induced colitis. Inflamm Bowel Dis (2010) 1.44
Impact of enhanced Staphylococcus DNA extraction on microbial community measures in cystic fibrosis sputum. PLoS One (2012) 1.40
Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls. MBio (2014) 1.40
Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy. Infect Immun (2012) 1.36
The gut microbiome in health and in disease. Curr Opin Gastroenterol (2015) 1.33
Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes (2011) 1.29
Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa. Am J Respir Cell Mol Biol (2006) 1.28
Heterogeneity in anatomic outcome of sacrospinous ligament fixation for prolapse: a systematic review. Obstet Gynecol (2007) 1.27
Impact of mecA gene testing and intervention by infectious disease clinical pharmacists on time to optimal antimicrobial therapy for Staphylococcus aureus bacteremia at a University Hospital. J Clin Microbiol (2008) 1.26
Application of a neutral community model to assess structuring of the human lung microbiome. MBio (2015) 1.25
Autopsy findings in eight patients with fatal H1N1 influenza. Am J Clin Pathol (2010) 1.25
Outcomes of transvaginal uterosacral ligament suspension: systematic review and metaanalysis. Am J Obstet Gynecol (2010) 1.23
Streptococcus intermedius causing infective endocarditis and abscesses: a report of three cases and review of the literature. BMC Infect Dis (2008) 1.23
Procalcitonin levels associate with severity of Clostridium difficile infection. PLoS One (2013) 1.22
Cigarette smoke exposure impairs pulmonary bacterial clearance and alveolar macrophage complement-mediated phagocytosis of Streptococcus pneumoniae. Infect Immun (2009) 1.22
Variation of the natural transformation frequency of Campylobacter jejuni in liquid shake culture. Microbiology (2003) 1.21
Pathogenesis of renal disease due to enterohemorrhagic Escherichia coli in germ-free mice. Infect Immun (2008) 1.20
Fibroblasts from long-lived bird species are resistant to multiple forms of stress. J Exp Biol (2011) 1.18
Necrotizing fasciitis: pathogenesis and treatment. Expert Rev Anti Infect Ther (2005) 1.18
A reminder reduces urinary catheterization in hospitalized patients. Jt Comm J Qual Patient Saf (2005) 1.18
A gene-targeted approach to investigate the intestinal butyrate-producing bacterial community. Microbiome (2013) 1.17
Real-time identification of serious infection in geriatric patients using clinical information system surveillance. J Am Geriatr Soc (2009) 1.17
Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun (2006) 1.16
Multicenter evaluation of the BD Max GBS assay for detection of group B streptococci in prenatal vaginal and rectal screening swab specimens from pregnant women. J Clin Microbiol (2010) 1.16